A prospective phase II study of combined androgen blockade in patients with androgen receptor-positive metastatic or locally advanced unresectable salivary gland carcinoma

BACKGROUND: There is no standard first-line chemotherapy for recurrent/metastatic (RM) or unresectable locally advanced (LA) salivary gland carcinoma (SGC). PATIENTS AND METHODS: We conducted a single institution, open-label, single arm, phase II trial of combined androgen blockade (CAB) for androge...

Descripción completa

Detalles Bibliográficos
Autores principales: Fushimi, C, Tada, Y, Takahashi, H, Nagao, T, Ojiri, H, Masubuchi, T, Matsuki, T, Miura, K, Kawakita, D, Hirai, H, Hoshino, E, Kamata, S, Saotome, T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5913639/
https://www.ncbi.nlm.nih.gov/pubmed/29211833
http://dx.doi.org/10.1093/annonc/mdx771

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5913639/
https://www.ncbi.nlm.nih.gov/pubmed/29211833
http://dx.doi.org/10.1093/annonc/mdx771

Ejemplares similares